On Dec. 9th, J-bio customers from Indonesia visited our company's project, Cansino Sph project and Shanghai Huiyong Pharmaceutical project, in Baoshan, Shanghai.
On the afternoon of Sept. 13th, 2022, the commencement ceremony of the Shanghai Huiyong Pharmaceutical High-end Preparation Industrialization Base Project was successfully held in the North Shanghai Biomedical Industrial Park, Baoshan District, Shanghai.
On August 26, more than 20 new employees of Tofflon Dehui in 2022 went to Tofflon's factories on study visit under the organization of personnel administration department.
As a high-tech enterprise, Tofflon Dehui, a wholly-owned subsidiary of Tofflon Science and Technology Group Co., Ltd. (SZ: 300171), has committed to its mission “Expertise in Biopharmaceutical Industry”, specializing in pharmaceutical factory construction, R&D (research and development) and production of purifying air-conditioning equipment and pharmaceutical water equipment.
We focus on high-level pharmaceutical fields, such as highly potent API and highly potent injectables, biological API and biological injectables. After serving hundreds of domestic and foreign pharmaceutical enterprises, Tofflon Dehui has accumulated a large amount of project experience and can provide clients with better service.·
Service BiomedicalAdhering to the mission of serving biopharmaceuticals with professional technology, we are a high-tech enterprise engaged in the development and production of various pharmaceutical equipment
High-end PharmaceuticalThe company focuses on high-end pharmaceuticals, such as antitumor APIs and antitumor agents, biologic stock solutions and biologics.
Quality ServiceWe have served hundreds of domestic and foreign pharmaceutical companies to provide better services for new and old customers.